Negatively regulating TLR4/NF-κB signaling via PPARα in endotoxin-induced uveitis

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 7, 2014, Pages 1109-1120

  Shen, Wei ^a   Gao, Yang ^a,b   Lu, Boyu ^b   Zhang, Qingjiong ^b   Hu, Yang ^c   Chen, Ying ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Endotoxin induced uveitis; LPS; PPAR ; TLR4

Indexed keywords

FENOFIBRATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNE UVEITIS; CELL SEPARATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENDOTOXIN-INDUCED UVEITIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATORY CELL; IRIDOCYCLITIS; LEUKOSTASIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION;

ENDOTOXIN INDUCED UVEITIS; LPS; PPARΑ; TLR4;

ANIMALS; CYTOKINES; ENDOTOXINS; FENOFIBRATE; LEUKOSTASIS; LIPOPOLYSACCHARIDES; MALE; NF-KAPPA B; PPAR GAMMA; RANDOM ALLOCATION; RATS; RATS, INBRED LEW; RETINALDEHYDE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION, GENETIC; UVEITIS;

EID: 84898944555     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.03.015     Document Type: Article

References (34)

1. Tabeta K., Georgel P., Janssen E., Du X., Hoebe K., Crozat K., Mudd S., Shamel L., Sovath S., Goode J., Alexopoulou L., Flavell R.A., Beutler B. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:3516-3521.
2. Beutler B., Hoebe K., Shamel L. Forward genetic dissection of afferent immunity: the role of TIR adapter proteins in innate and adaptive immune responses. C. R. Biol. 2004, 327:571-580.
3. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
4. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088.
5. Hornef M.W., Normark B.H., Vandewalle A., Normark S. Intracellular recognition of lipopolysaccharide by Toll-like receptor 4 in intestinal epithelial cells. J. Exp. Med. 2003, 198:1225-1235.
6. Backhed F., Hornef M. Toll-like receptor 4-mediated signaling by epithelial surfaces: necessity or threat?. Microbes Infect. 2003, 5:951-959.
7. Rosenbaum J.T., McDevitt H.O., Guss R.B., Egbert P.R. Endotoxin-induced uveitis in rats as a model for human disease. Nature 1980, 286:611-613.
8. Espiritu C.G., Gelber R., Ostler H.B. Chronic anterior uveitis in leprosy: an insidious cause of blindness. Br. J. Ophthalmol. 1991, 75:273-275.
9. Ronday M.J., Stilma J.S., Barbe R.F., Kijlstra A., Rothova A. Blindness from uveitis in a hospital population in Sierra Leone. Br. J. Ophthalmol. 1994, 78:690-693.
10. Shen D.F., Buggage R.R., Eng H.C., Chan C.C. Cytokine gene expression in different strains of mice with endotoxin-induced uveitis (EIU). Ocul. Immunol. Inflamm. 2000, 8:221-225.
11. Mathison J., Wolfson E., Steinemann S., Tobias P., Ulevitch R. Lipopolysaccharide (LPS) recognition in macrophages. Participation of LPS-binding protein and CD14 in LPS-induced adaptation in rabbit peritoneal exudate macrophages. J. Clin. Invest. 1993, 92:2053-2059.
12. Li Q., Peng B., Whitcup S.M., Jang S.U., Chan C.C. Endotoxin induced uveitis in the mouse: susceptibility and genetic control. Exp. Eye Res. 1995, 61:629-632.
13. Elijah I.E., Borsheim E., Maybauer D.M., Finnerty C.C., Herndon D.N., Maybauer M.O. Role of the PPAR-alpha agonist fenofibrate in severe pediatric burn. Burns 2012, 38:481-486.
14. Chen Y., Hu Y., Lin M., Jenkins A.J., Keech A.C., Mott R., Lyons T.J., Ma J.X. Therapeutic effects of PPARalpha agonists on diabetic retinopathy in type 1 diabetes models. Diabetes 2013, 62:261-272.
15. Krysiak R., Gdula-Dymek A., Okopien B. Effect of simvastatin and fenofibrate on cytokine release and systemic inflammation in type 2 diabetes mellitus with mixed dyslipidemia. Am. J. Cardiol. 2011, 107:1010-1018. (e1011).
16. Krysiak R., Gdula-Dymek A., Okopien B. The effect of fenofibrate on lymphocyte release of proinflammatory cytokines and systemic inflammation in simvastatin-treated patients with atherosclerosis and early glucose metabolism disturbances. Basic Clin. Pharmacol. Toxicol. 2013, 112:198-202.
17. Price E.T., Welder G.J., Zineh I. Modulatory effect of fenofibrate on endothelial production of neutrophil chemokines IL-8 and ENA-78, Cardiovasc. Drugs Ther. 2012, 26:95-99.
18. Pouvreau I., Zech J.C., Thillaye-Goldenberg B., Naud M.C., Van Rooijen N., de Kozak Y. Effect of macrophage depletion by liposomes containing dichloromethylene-diphosphonate on endotoxin-induced uveitis. J. Neuroimmunol. 1998, 86:171-181.
19. Chen Y., Hu Y., Lu K., Flannery J.G., Ma J.X. Very low density lipoprotein receptor, a negative regulator of the wnt signaling pathway and choroidal neovascularization. J. Biol. Chem. 2007, 282:34420-34428.
20. Saraswathy S., Nguyen A.M., Rao N.A. The role of TLR4 in photoreceptor {alpha}a crystalline upregulation during early experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 2010, 51:3680-3686.
21. Su S.B., Silver P.B., Grajewski R.S., Agarwal R.K., Tang J., Chan C.C., Caspi R.R. Essential role of the MyD88 pathway, but nonessential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity. J. Immunol. 2005, 175:6303-6310.
22. Okunuki Y., Usui Y., Nakagawa H., Tajima K., Matsuda R., Ueda S., Hattori T., Kezuka T., Goto H. Peroxisome proliferator-activated receptor-gamma agonist pioglitazone suppresses experimental autoimmune uveitis. Exp. Eye Res. 2013, 116:291-297.
23. Yin Y., Hou G., Li E., Wang Q., Kang J. PPAR gamma agonists regulate tobacco smoke-induced Toll like receptor 4 expression in alveolar macrophages. Respir. Res. 2014, 15:28.
24. Hu K., Yang Y., Tu Q., Luo Y., Ma R. Alpinetin inhibits LPS-induced inflammatory mediator response by activating PPAR-gamma in THP-1-derived macrophages. Eur. J. Pharmacol. 2013, 721:96-102.
25. Sakamoto J., Kimura H., Moriyama S., Odaka H., Momose Y., Sugiyama Y., Sawada H. Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone. Biochem. Biophys. Res. Commun. 2000, 278:704-711.
26. Muranaka K., Yanagi Y., Tamaki Y., Usui T., Kubota N., Iriyama A., Terauchi Y., Kadowaki T., Araie M. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model. Invest. Ophthalmol. Vis. Sci. 2006, 47:4547-4552.
27. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 2006, 116:3015-3025.
28. Pal D., Dasgupta S., Kundu R., Maitra S., Das G., Mukhopadhyay S., Ray S., Majumdar S.S., Bhattacharya S. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat. Med. 2012, 18:1279-1285.
29. Wong S.W., Kwon M.J., Choi A.M., Kim H.P., Nakahira K., Hwang D.H. Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J. Biol. Chem. 2009, 284:27384-27392.
30. Xu H.E., Stanley T.B., Montana V.G., Lambert M.H., Shearer B.G., Cobb J.E., McKee D.D., Galardi C.M., Plunket K.D., Nolte R.T., Parks D.J., Moore J.T., Kliewer S.A., Willson T.M., Stimmel J.B. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Nature 2002, 415:813-817.
31. Horlein A.J., Naar A.M., Heinzel T., Torchia J., Gloss B., Kurokawa R., Ryan A., Kamei Y., Soderstrom M., Glass C.K., et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 1995, 377:397-404.
32. Chen J.D., Evans R.M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 1995, 377:454-457.
33. Nagy L., Kao H.Y., Chakravarti D., Lin R.J., Hassig C.A., Ayer D.E., Schreiber S.L., Evans R.M. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 1997, 89:373-380.
34. Laherty C.D., Yang W.M., Sun J.M., Davie J.R., Seto E., Eisenman R.N. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 1997, 89:349-356.